Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study
Chia-Chih Kuo, Min‐Hsiang Chuang, Chun‐Hsien Li, Po‐Yu Huang, Hsing‐Tao Kuo, Chih‐Cheng Lai
Topics & Concepts
MedicineNonalcoholic fatty liver diseaseHepatologyInternal medicineType 2 diabetesAdverse effectCohortDiabetes mellitusCohort studyDiseaseFatty liverSemaglutideLiver diseaseGastroenterologyEndocrinologyLiraglutideDiabetes Treatment and ManagementLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins